BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khandpur S, Mishra P, Mishra S, Tiwari S. Challenges in predictive modelling of chronic kidney disease: A narrative review. World J Nephrol 2024; 13(3): 97214 [PMID: 39351189 DOI: 10.5527/wjn.v13.i3.97214]
URL: https://www.wjgnet.com/2220-6124/full/v13/i3/97214.htm
Number Citing Articles
1
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney diseaseActa Pharmacologica Sinica 2025; 46(11): 2975 doi: 10.1038/s41401-025-01598-4
2
Tingting Yuan, Hong Wang, Ting Kang, Weihua Wu, Santao Ou. Advancements in the non-invasive diagnosis of renal fibrosisFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1646412
3
Chen-Hui Jiang, Shui-Juan Zhang, Ping Li, Hua Miao, Ying-Yong Zhao. Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategiesPhytomedicine 2025; 148: 157496 doi: 10.1016/j.phymed.2025.157496
4
Weiwei Li, Lumiao Chen, Linsen Jiang, Zhijian Zhang, Kai Song. The prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in chronic kidney disease: a population-based analysis of NHANES data (1999–2018)Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1589173
5
Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao. Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological MechanismsDrug Design, Development and Therapy 2025; : 9457 doi: 10.2147/DDDT.S557114
6
Lan Wang, Jinwei Wang, Wei Wu, Xue Xue, Tianmai He, Shenhui Lv, Wenjing Wu, Qingqing Sun, Quan Zhou, Siyang Zhang, Sipin Han, Yu Zhao, Xinrong Zou, Dingkun Gui, Xiaoqin Wang. Prognostic Factors of Diabetic Kidney Disease and Therapeutic Effects of Shenyuan Granules: A Real-World Prospective Cohort StudyIntegrative Medicine in Nephrology and Andrology 2025; 12(4) doi: 10.1097/IMNA-D-25-00031
7
Bing Zhang, Liufei Deng. Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safetyFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1574693
8
Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai. Fecal microbiota transplantation is a promising therapy for kidney diseasesFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1628722
9
Xingfu Ji, Guilin Jing, Haoqi Sun, Xuan Li, Xuexun Chen. Case report and literature review: IgG4-related tubulointerstitial nephritis coexistent with systemic lupus erythematosusFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1585351
10
Haojie Liu, Xiadan Xiang, Chengqian Shi, Jiaowei Guo, Ting Ran, Jinglian Lin, Futing Dong, Jie Yang, Hua Miao. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targetsChemico-Biological Interactions 2025; 421: 111784 doi: 10.1016/j.cbi.2025.111784
11
Yumeng Li, Yousuf Waheed, Dong Sun. Exosomes and Renal Fibrosis: Diagnostic Value, Therapeutic Potential and ChallengesInternational Journal of Nanomedicine 2025; : 11267 doi: 10.2147/IJN.S529311
12
Hao-Yu Feng, Yi-Qi Wang, Jianhua Yang, Hua Miao, Ying-Yong Zhao, Xiaojuan Li. Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney DiseaseDrug Design, Development and Therapy 2025; : 5739 doi: 10.2147/DDDT.S521265
13
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trialFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637